Clinical Trial Update: Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chemotherapies in combination with targeted therapies and their effect on resection rates of hepatic metastases in colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: UNICANCER | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED